Yet the law remains the same. Under section 101 of the National Health Act 1953, the PBAC must prioritise a medicine's effectiveness and cost compared with alternative therapies. The Act does not require the consideration of, or make any reference to, consumer input. …
Does new report suggest that patient voice reforms are stalling?
November 4, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Sydney summit program focused on the reshaping power of AI
November 4, 2026 - - Latest News -
Does new report suggest that patient voice reforms are stalling?
November 4, 2026 - - Latest News -
Is the reluctance to revisit term limits because they are such an obvious change?
November 4, 2026 - - Latest News -
Report finds 196 missing medicines and billions in unreinvested PBS savings
November 3, 2026 - - Latest News -
Medicines industry faces tough PBS talks, but will it be the most challenging ever?
November 3, 2026 - - Latest News -
Diabetes scheme registrations fall as health department points to GLP-1 use
November 3, 2026 - - Latest News -
Older Australians given three weeks to have their say on in-home aged care services list
November 3, 2026 - - Latest News